ArticleFEBS open bio2026

Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.

Saira Munshani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.